KromaTiD Appoints Nathan Wood as Chief Executive Officer
By: Colorado BioScience Association Date: 08/16/2021
KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the former President and CEO of Swift Biosciences, Inc., a provider of research tools in the genomics and related health care industry. Wood replaces Christopher Tompkins, who will assume the role of Chief Technology Officer.
“Nathan has well documented track record of success commercializing research tools. He has been an executive and C-level contributor at a number of leading life science companies. He is passionate about KromaTiD’s technology platform and the unique opportunities it has within the large and growing genomics market,” said Dr. Opgenorth, chairman of the company’s board of directors. “In short, he is a great business and culture fit for KromaTiD and we are confident he will lead the Company to the next stage and establish KromaTiD as yet another pioneering Colorado bioscience company in the genomics space.”
During his tenure with Swift Biosciences, Wood raised private funding totaling more than $15 million to develop and commercialize a proprietary set of NGS library preparation products that served research and clinical laboratory markets, substantially grew revenue, and merged Swift with IDT, a Danaher company.
“I am excited to be a part of this promising opportunity. The company has the foundation of protected intellectual property, product development and validation, market opportunity, management team experience, and community resources to be successful,” said Wood. “KromaTiD’s innovative products and established reputation represent a great platform to capitalize on the significant growth in Regenerative Medicine, Gene Therapy and Cancer Diagnostics”
Find out more in the press release.